Active and passive immunisation against respiratory syncytial virus (Q33782438)

29 July 2017

1 reference

title

Active and passive immunisation against respiratory syncytial virus (English)

1 reference

29 July 2017

1 reference

Zambon M

1

1 reference

29 July 2017

publication date

1 October 1999

1 reference

Reviews in Medical Virology

29 July 2017

published in

1 reference

29 July 2017

volume

9

1 reference

29 July 2017

issue

4

1 reference

29 July 2017

page(s)

227-236

1 reference

From the National Institute of Allergy and Infectious Diseases and the World Health Organization. Respiratory syncytial and parainfluenza viruses

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Risk factors for mechanical ventilation in respiratory syncytial virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study of admission and management variation in patients hospitalized with respiratory syncytial viral lower respiratory tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

The clinical spectrum of respiratory syncytial virus disease in The Gambia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Respiratory syncytial virus and influenza A infections in the hospitalized elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Nosocomial Respiratory Syncytial Virus Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Respiratory Syncytial Virus Infections within Families

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Concurrent respiratory syncytial virus and influenza A infections in the institutionalized elderly and chronically ill.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Respiratory syncytial virus or influenza?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Prospective controlled study of four infection-control procedures to prevent nosocomial infection with respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Respiratory syncytial virus infection in immunocompromised adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Respiratory syncytial virus pneumonia in hospitalized adult patients with leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Community respiratory virus infections among hospitalized adult bone marrow transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Two distinct subtypes of human respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Evaluation of a live, attenuated respiratory syncytial virus vaccine in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Immunogenicity of purified F glycoprotein of respiratory syncytial virus: clinical and immune responses to subsequent natural infection in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Immunological determinants of disease caused by respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Distinct types of lung disease caused by functional subsets of antiviral T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Immunopathological mechanisms in respiratory syncytial virus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Virus-specific CD8+ T Lymphocytes Downregulate T Helper Cell Type 2 Cytokine Secretion and Pulmonary Eosinophilia during Experimental Murine Respiratory Syncytial Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Interleukin-12 Treatment during Immunization Elicits a T Helper Cell Type 1-like Immune Response in Mice Challenged with Respiratory Syncytial Virus and Improves Vaccine Immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Protective and disease-enhancing immune responses to respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

An epidemic of respiratory syncytial virus in elderly people: clinical and serological findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Humoral immunity to respiratory syncytial virus infection in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Relationship of Serum Antibody to Risk of Respiratory Syncytial Virus Infection in Elderly Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Reverse Genetics Meets the Nonsegmented Negative-Strand RNA Viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

A comparison in chimpanzees of the immunogenicity and efficacy of live attenuated respiratory syncytial virus (RSV) temperature-sensitive mutant vaccines and vaccinia virus recombinants that express the surface glycoproteins of RSV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

A further attenuated derivative of a cold-passaged temperature-sensitive mutant of human respiratory syncytial virus retains immunogenicity and protective efficacy against wild-type challenge in seronegative chimpanzees

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Nucleotide sequence analysis of the respiratory syncytial virus subgroup A cold-passaged (cp) temperature sensitive (ts) cpts-248/404 live attenuated virus vaccine candidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Evaluation of Two Live, Cold‐Passaged, Temperature‐Sensitive Respiratory Syncytial Virus Vaccines in Chimpanzees and in Human Adults, Infants, and Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Protective immunity against respiratory syncytial virus in early life after murine maternal or neonatal vaccination with the recombinant G fusion protein BBG2Na

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Antigenic structure, evolution and immunobiology of human respiratory syncytial virus attachment (G) protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Subgroup specific protection of mice from respiratory syncytial virus infection with peptides encompassing the amino acid region 174-187 from the G glycoprotein: the role of cysteinyl residues in protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Eliminating a region of respiratory syncytial virus attachment protein allows induction of protective immunity without vaccine-enhanced lung eosinophilia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Analysis of linear epitopes recognised by the primary human antibody response to a variable region of the attachment (G) protein of respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro : Clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in ambulatory adults over age 60.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in the institutionalized elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Safety and Immunogenicity of a Purified F Protein Respiratory Syncytial Virus (PFP‐2) Vaccine in Seropositive Children with Bronchopulmonary Dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Sequential annual administration of purified fusion protein vaccine against respiratory syncytial virus in children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Protection of BALE/c mice from respiratory syncytial virus infection by immunization with a synthetic peptide derived from the G glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Treatment and prevention options for respiratory syncytial virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Initiation of cytotoxic T-cell response and protection of Balb/c mice by vaccination with an experimental ISCOMs respiratory syncytial virus subunit vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Expression of the G glycoprotein gene of human respiratory syncytial virus in Salmonella typhimurium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Role of maternal antibody in pneumonia and bronchiolitis due to respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Antibodies to respiratory syncytial virus polypeptides and their significance in human infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Intravenous immunoglobulin treatment of respiratory syncytial virus infections in infants and young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Comparison of antibody concentrations and protective activity of respiratory syncytial virus immune globulin and conventional immune globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Use of intravenous gamma globulin to passively immunize high-risk children against respiratory syncytial virus: safety and pharmacokinetics. The RSVIG Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

A number-needed-to-treat analysis of the use of respiratory syncytial virus immune globulin to prevent hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Respiratory Syncytial Virus Immune Globulin Treatment of RSV Lower Respiratory Tract Infection in Previously Healthy Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Respiratory syncytial virus immune globulin for prophylaxis against respiratory syncytial virus disease in infants and children with congenital heart disease. The Cardiac Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Assault against respiratory syncytial virus: beginning of an era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Evaluation of the protective efficacy of reshaped human monoclonal antibody RSHZ19 against respiratory syncytial virus in cotton rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

The pharmacokinetics, antigenicity, and fusion-inhibition activity of RSHZ19, a humanized monoclonal antibody to respiratory syncytial virus, in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Isolation of a second recombinant human respiratory syncytial virus monoclonal antibody fragment (Fab RSVF2-5) that exhibits therapeutic efficacy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Monoclonal antibody neutralization escape mutants of respiratory syncytial virus with unique alterations in the attachment (G) protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Outbreak of respiratory syncytial virus infection in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Safety and immunogenicity of a subunit respiratory syncytial virus vaccine in children 24 to 48 months old.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. The PREVENT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

Respiratory Syncytial Virus PREVENT Study Questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1654%28199910%2F12%299%3A4%3C227%3A%3AAID-RMV251%3E3.0.CO%3B2-K

10.1002/(SICI)1099-1654(199910/12)9:4<227::AID-RMV251>3.0.CO;2-K

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference